Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Tables)

v3.24.1.u1
Stockholders’ Equity (Tables)
 12 Months Ended
Dec. 30, 2023
Stockholders' Equity Note [Abstract]  
Summary of Stock Options Activity
The following table summarizes stock option activity for the fiscal years ended December 30, 2023, and December 31, 2022 (Aggregate Intrinsic Value in $000’s):
Options
Outstanding 		Weighted
Average
Exercise
Price		 Aggregate
Intrinsic
Value		 Weighted
Average
Remaining
Contractual
Life
Outstanding at January 1, 2022 117,500 $ 7.16  $ 21  7.0
Cancelled/expired (7,500)
Outstanding at December 31, 2022 110,000 6.27  —  6.5
Granted 10,000 1.53 
Cancelled/expired (6,000) — 
Outstanding at December 30, 2023 114,000 $ 5.68  $ —  6.1
Exercisable at December 30, 2023 114,000 $ 5.68  $ —  6.1
Schedule of Exercise Price for Stock Options Outstanding and Exercisable Outstanding
The exercise price for stock options outstanding and exercisable outstanding at December 30, 2023 is as follows:
Outstanding Exercisable
Number of Options Exercise Price ($) Number of Options Exercise Price ($)
6,000
$17.35 to $23.45
 6,000
$17.35 to $23.45
—
$11.10 to $15.00
 —
$11.10 to $15.00
42,000
$5.70 to $9.90
 42,000
$5.70 to $9.90
66,000
$3.54 to $5.25
 66,000
$3.54 to $5.25
114,000 114,000
Summary of Information About Non-vested Shares Outstanding
The following table summarizes information about the Company’s non-vested shares outstanding as of December 30, 2023 and December 31, 2022:
Non-vested Shares Number of
Shares
Non-vested at January 1, 2022 7,500
Vested (7,500)
Non-vested at December 31, 2022 —
Granted 10,000
Vested (10,000)
Non-vested at December 30, 2023 —